---
title: "BINSA bill could protect U.S. biotech — but a loophole may enable ‘Eurowashing’"
id: "stat-news-4-opinion-stat-a-bill-is-supposed-to-protect-u-s-biotech-from-chinese-competition"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-4-opinion-stat-a-bill-is-supposed-to-protect-u-s-biotech-from-chinese-competition"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/08/27/binsa-biotech-china-eurowashing-geography-clinical-trials/?utm_campaign=rss"
published_at: "2026-08-27T08:30:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# BINSA bill could protect U.S. biotech — but a loophole may enable ‘Eurowashing’
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-4-opinion-stat-a-bill-is-supposed-to-protect-u-s-biotech-from-chinese-competition
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/2026/08/27/binsa-biotech-china-eurowashing-geography-clinical-trials/?utm_campaign=rss)
- **Published At:** 2026-08-27T08:30:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Bipartisan legislation called the Biotech Investment National Security Act (**BINSA**) was introduced to expand federal oversight of routine biotechnology activities, including pharmaceutical development, biologics manufacturing, and clinical research and development. - BINSA is presented as a national-security measure intended to curb offshoring of sensitive biotech work to China and follows the December 2025 **Comprehensive Outbound Investment National Security (COINS) Act**. - The bill’s announcement was prompted in part by multibillion-dollar R&D and licensing deals that **Pfizer** and **Bristol Myers Squibb** reportedly struck with Chinese biopharma firms. - Sponsors argue BINSA would guard U.S. medical research and innovation from foreign actors perceived as strategic competitors; rhetoric from Rep. John Moolenaar singled out pharma deals with Chinese companies. - The authors of the STAT opinion piece raise concern that BINSA could produce an unintended effect termed “**Eurowashing**,” where companies reroute activities through Europe or other jurisdictions to comply superficially with U.S. restrictions while continuing relationships with Chinese partners. - The publicly available portion of the STAT article is limited; the full analysis and supporting detail are behind a STAT+ paywall. Specific provisions of BINSA, the nature of the identified loophole, evidence for Eurowashing, and recommended policy fixes were not reported in the accessible source text. - The article’s authors are executives at Optimapharm and frame the issue as one that could significantly reshuffle global drug development dynamics, potentially benefiting non-U.S. jurisdictions. - Because the STAT piece is paywalled, critical details such as legislative text excerpts, case examples, data, and proposed amendments are not available in the source provided.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/2026/08/27/binsa-biotech-china-eurowashing-geography-clinical-trials/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-white.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * Email this article * [Share this article](https://www.statnews.com/2026/08/27/binsa-biotech-china-eurowashing-geography-clinical-trials/?utm_campaign=rss) [Cancer](https://www.statnews.com/topic/cancer/) [Hospitals](https://www.statnews.com/category/hospitals/) [Mental Health](https://www.statnews.com/topic/mental-health/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) Reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [STAT Events](https://www.statnews.com/events/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) * [Science, Shattered](https://www.statnews.com/american-science-shattered/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Wunderkinds 2026](https://www.statnews.com/wunderkinds-nominate/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) What's the word? Test your knowledge with our new weekday mini crossword [ Start solving ](https://www.statnews.com/stat-mini-crossword/) [STAT Plus](https://www.statnews.com/stat-plus/)Opinion[Opinions+](https://www.statnews.com/category/opinions-plus/) # A bill is supposed to protect U.S. biotech from Chinese competition. But there’s a loophole ## BINSA could lead to ‘Eurowashing’ * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * Email this article * [Share this article](https://www.statnews.com/2026/08/27/binsa-biotech-china-eurowashing-geography-clinical-trials/?utm_campaign=rss) ![](https://www.statnews.com/wp-content/uploads/2026/08/AdobeStock_408515005-645x645.jpeg) Adobe By Pavle Vukojevic, Miguel Salcedo, and Paul Miller Aug. 27, 2026 Vukojevic, Salcedo, and Miller are executives at Optimapharm. Bipartisan legislation under review in Congress has the potential to significantly rejigger global drug development — and the biggest beneficiaries may not be American. The bill, titled the Biotech Investment National Security Act (BINSA), was introduced [in June](https://chinaselectcommittee.house.gov/media/press-releases/moolenaar-dingell-introduce-legislation-to-prevent-offshoring-biotech-industry-to-china) to significantly broaden federal oversight of everyday biotechnology activities, including pharmaceutical development, biologics manufacturing, and clinical R&D. The policy is an add-on to the restrictions of the Comprehensive Outbound Investment National Security (COINS) Act filed in [December 2025](https://www.congress.gov/bill/119th-congress/senate-bill/3555). Advertisement BINSA’s sponsors frame the additional policy as necessary to protect U.S. national security interests in medical research and innovation. The policy was announced following two multibillion-dollar R&D and licensing deals agreed by Pfizer and Bristol Myers Squibb with Chinese biopharma companies. In a [press release about the bill](https://chinaselectcommittee.house.gov/media/press-releases/moolenaar-dingell-introduce-legislation-to-prevent-offshoring-biotech-industry-to-china), co-sponsor Rep. John Moolenaar (R-Mich.) called out the pharma companies for “making dangerous deals with Chinese biotech companies that threaten the future of American pharmaceutical production.” STAT+ Exclusive Story Already have an account? [Log in](https://www.statnews.com/login/) ![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-breaker-bg.png) [ ![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo-white.svg) ](https://www.statnews.com/stat-plus/) ## This article is exclusive to STAT+ subscribers ### Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? [Log in](https://www.statnews.com/login/) Individual plans Group plans Monthly $39 Totals $468 per year [$39/month](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-monthly-39-0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-monthly-39-0) Totals $468 per year Starter $30 for 3 months, then $399/year [$30 for 3 months](https://www.statnews.com/stat-plus/subscribe/?plan=3mo30_yearly_pw) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=3mo30_yearly_pw) Then $399/year Annual $399 Save 15% [$399/year](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-annually-399-0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-annually-399-0) Save 15% 11+ Users Custom Savings start at 25%! [Request A Quote](https://www.statnews.com/stat-plus/group-subscriptions/) [Request A Quote](https://www.statnews.com/stat-plus/group-subscriptions/) Savings start at 25%! 2-10 Users $300 Annually per user [$300/year](https://www.statnews.com/stat-plus/subscribe/?plan=stat_plus_groups_self_serve_0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat_plus_groups_self_serve_0) $300 Annually per user [View All Plans](https://www.statnews.com/stat-plus/) [![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo.svg)](https://www.statnews.com/stat-plus/) To read the rest of this story subscribe to STAT+. [Subscribe](https://www.statnews.com/stat-plus/) [Log In](https://www.statnews.com/login/) [biotechnology](https://www.statnews.com/topic/biotechnology/), [China](https://www.statnews.com/topic/china/), [Clinical trials](https://www.statnews.com/topic/clinical-trials/), [Congress](https://www.statnews.com/topic/congress/), [Pharmaceuticals](https://www.statnews.com/topic/pharmaceuticals/), [Policy](https://www.statnews.com/topic/policy/), [STAT+](https://www.statnews.com/topic/stat-plus/) [Submit a correction request](https://www.statnews.com/contact/?how_can_we_help_=Editorial%20Correction%20Request)[Reprints](https://www.parsintl.com/publications/stat/) 1. Pavle Vukojevic 2. Miguel Salcedo 3. Paul Miller ![](https://www.statnews.com/wp-content/themes/stat/images/article-new/envelope-open.svg) ![](https://www.statnews.com/wp-content/uploads/2023/06/First-Opinion-Logo-Black-640x319.png) ### Newsletter The smartest thinkers in life sciences on what's happening — and what's to come Please enter a valid email address. Sign Up Your data will be processed in accordance with our [Privacy Policy](https://www.statnews.com/privacy/) and [Terms of Service](https://www.statnews.com/terms-conditions/). You may opt out of receiving STAT communications at any time. Advertisement Most Popular 1. ![](https://www.statnews.com/wp-content/uploads/2026/08/LongLab_Immunofluorescence-of-the-biosynthetic-enzyme-for-exercise-inducible-Lac-Phe-Cndp2-green-and-nuclei-DAPI-blue-in-mouse-gut-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [A pill that mimics exercise? Early results on drug designed to maintain both weight loss and muscle mass](https://www.statnews.com/2026/08/18/enveda-pill-mimics-exercise-phase-one-trial-leptin-weight-loss-maintenance/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/08/F0372048-Lipoprotein_A_particle_illustration-1-e1787689211295-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [New treatments for common cardiovascular risk factor near the market, with billions at stake](https://www.statnews.com/2026/08/26/lp-a-drugs-novartis-amgen-lilly-potential-heart-disease-blockbuster/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/08/Revmed_campus2-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [FDA approves new pancreatic cancer drug expected to usher in new era of treatment](https://www.statnews.com/2026/08/26/pancreatic-cancer-drug-rasonque-approved/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/08/AdobeStock_180917809-80x80.jpeg) [Nurse practitioner trainees find themselves stymied by shortage of clinical mentors](https://www.statnews.com/2026/08/24/nurse-practitioner-preceptor-shortage-clinical-placement-challenges/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/08/AdobeStock_451619906_Editorial_Use_Only-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Sword Health to acquire Headspace, according to filing](https://www.statnews.com/2026/08/25/sword-health-to-acquire-headspace-per-regulatory-filing/) #### [ Reports ](https://reports.statnews.com/) [ ![](https://www.statnews.com/wp-content/uploads/2026/08/2026_CancerReport_ReportCover-328x424.jpg) Explore Cancer’s transformational moments: KRAS, CAR-T, immunotherapy, and more ](https://reports.statnews.com/products/cancer-transformational-moments-advances-in-kras-car-t-immunotherapy) Advertisement #### [Events](https://www.statnews.com/events/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/924_Samsung_VirtualEvent_Wordpress_FeaturedImage-80x80.jpg) Biosimilars: Have We Reached an Inflection Point? Virtual Sep 24 ](https://www.statnews.com/event/biosimilars-what-is-next-virtual-event-sept-2026/) [ ![](https://www.statnews.com/wp-content/uploads/2026/01/Flagship2026_Wordpress_CalendarImageRegGoLive-1-80x80.jpg) 2026 STAT Summit Boston, MA Oct 14 ](https://www.statnews.com/event/2026-stat-summit/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/2026_DD_OfficeHours_VirtualEvent_Wordpress_CalendarImage-80x80.jpg) Office Hours with Isabella Cueto and Lev Facher Virtual Jul 29 ](https://www.statnews.com/event/deadliest-drug-series-office-hours-ama-july-2026/) Most Read in [STAT+](https://www.statnews.com/stat-plus/) 1. ![](https://www.statnews.com/wp-content/uploads/2026/08/image-15-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Inside Moderna and Merck’s cancer vaccine triumph](https://www.statnews.com/2026/08/24/inside-moderna-and-merck-cancer-vaccine-triumph/) 2. ![](https://www.statnews.com/wp-content/uploads/2020/02/AdobeStock_284333299-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial](https://www.statnews.com/2026/08/19/mrna-cancer-vaccine-trial-melanoma-merck-moderna/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/08/Revmed_campus2-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [FDA approves new pancreatic cancer drug expected to usher in new era of treatment](https://www.statnews.com/2026/08/26/pancreatic-cancer-drug-rasonque-approved/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/08/AP26111614763455-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [HHS document offers new clues to Kennedy’s vaccine plans](https://www.statnews.com/2026/08/21/rfi-reveals-possible-kennedy-strategy-vaccine-policy-changes/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/08/GettyImages-2270934863-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Comments on OMB research rule mysteriously removed from federal website](https://www.statnews.com/2026/08/25/russell-vought-omb-funding-comments-daughter-benefited-nih-research/) #### Recommended ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Biotech Biotech August 27, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: The mystery of Moderna’s magic algorithm ](https://www.statnews.com/2026/08/27/moderna-merck-cancer-vaccine-secret-ingredient-an-algorithm/) By [Jason Mast](https://www.statnews.com/staff/jason-mast/), [Matthew Herper](https://www.statnews.com/staff/matthew-herper/), and [Angus Chen](https://www.statnews.com/staff/angus-chen/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Biotech Biotech August 26, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: FDA approves new pancreatic cancer drug expected to usher in new era of treatment ](https://www.statnews.com/2026/08/26/pancreatic-cancer-drug-rasonque-approved/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) and [Angus Chen](https://www.statnews.com/staff/angus-chen/) Advertisement ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) The Readout The Readout August 26, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Key data on a new class of cardio drugs are coming ](https://www.statnews.com/2026/08/26/biotech-news-key-data-on-new-class-of-cardio-drugs-coming/) By [Elaine Chen](https://www.statnews.com/staff/elaine-chen/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) AI Prognosis AI Prognosis August 26, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: AI biotech Insitro’s Daphne Koller on how to speed up clinical trials ](https://www.statnews.com/2026/08/26/biotech-insitro-ceo-daphne-koller-speeding-up-clinical-trials-ai-prognosis/) By [Brittany Trang](https://www.statnews.com/staff/brittany-trang/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Biotech Biotech August 25, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: After a years-long slump, Massachusetts biopharma sector has come roaring back in 2026 ](https://www.statnews.com/2026/08/25/massachusetts-biotech-slump-then-turnaround/) By Jonathan Saltzman — Boston Globe #### Subscriber Picks 1. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Capricor Therapeutics' Duchenne treatment is heading for an FDA rejection ](https://www.statnews.com/2026/08/20/capricor-therapeutics-duchenne-treatment-fda/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 2. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Inside Moderna and Merck’s cancer vaccine triumph ](https://www.statnews.com/2026/08/24/inside-moderna-and-merck-cancer-vaccine-triumph/) By [Matthew Herper](https://www.statnews.com/staff/matthew-herper/), [Jason Mast](https://www.statnews.com/staff/jason-mast/), and [Angus Chen](https://www.statnews.com/staff/angus-chen/) 3. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: One of the most consequential years for cancer treatment, ever ](https://www.statnews.com/2026/08/20/cancer-vaccine-merck-moderna-biotech-observations/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 4. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: What Epic did — and didn’t — say about AI at its annual meeting ](https://www.statnews.com/2026/08/19/ai-prognosis-what-epic-did-and-didnt-say-about-ai-at-its-annual-meeting
## Related Clinical Research

- [Cassidy report faults FDA oversight of mifepristone manufacturers](https://medichelpline.com/clinical-feed/stat-news-5-stat-cassidy-criticizes-fda-oversight-of-abortion-pill-manufacturers-in-new.md)
- [Employers Cutting GLP-1 Coverage and a Dip in Massachusetts Biotech Employment](https://medichelpline.com/clinical-feed/stat-news-5-stat-pharmalittle-we-re-reading-about-a-gsk-shingles-shot-u-s-employers.md)
- [Cardiac-targeted delivery strategies for advanced therapies in heart disease](https://medichelpline.com/clinical-feed/pubmed-42284133.md) (DOI: 10.1093/eurheartj/ehag432)
- [Keto Diet Shows Superior Metabolic Benefits Over Mediterranean and Low-Fat Diets](https://medichelpline.com/clinical-feed/medical-news-today-1-keto-diet-may-have-metabolic-advantages-over-mediterranean-low-fat-diets.md)
- [GLP-1 receptor agonists and PMOS: evidence, mechanisms, and who may benefit](https://medichelpline.com/clinical-feed/medical-news-today-0-can-glp-1s-really-help-treat-pmos-experts-answer-3-key-questions.md)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.